{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:54:30Z","timestamp":1776851670695,"version":"3.51.2"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of PR China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["81402900"],"award-info":[{"award-number":["81402900"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["JKQZ2013028"],"award-info":[{"award-number":["JKQZ2013028"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.jpba.2015.08.023","type":"journal-article","created":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T15:01:41Z","timestamp":1440255701000},"page":"37-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Rapid, sensitive and selective HPLC\u2013MS\/MS method for the quantification of topically applied besifloxacin in rabbit plasma and ocular tissues: Application to a pharmacokinetic study"],"prefix":"10.1016","volume":"117","author":[{"given":"Xiao-Fei","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai-Yang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Song","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Xiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Xiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2015.08.023_bib0005","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/jop.2006.0137","article-title":"Nonclinical pharmacodynamics, pharmacokinetics, and safety of BOL-303224-A, a novel fluoroquinolone antimicrobial agent for topical ophthalmic use","volume":"23","author":"Ward","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2015.08.023_bib0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4137\/OED.S4102","article-title":"Besifloxacin ophthalmic suspension: emerging evidence of its therapeutic value in bacterial conjunctivitis","volume":"3","author":"Khimdas","year":"2011","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.jpba.2015.08.023_bib0015","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1128\/AAC.00418-09","article-title":"Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria","volume":"53","author":"Haas","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2015.08.023_bib0020","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jac\/dkq127","article-title":"Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae","volume":"65","author":"Haas","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2015.08.023_bib0025","first-page":"1369","article-title":"Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility profile","volume":"5","author":"Haas","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jpba.2015.08.023_bib0030","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the antibiotic resistance monitoring in ocular micro organisms (armor) 2009 surveillance study","volume":"152","author":"Haas","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jpba.2015.08.023_bib0035","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.clinthera.2009.03.010","article-title":"Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study","volume":"31","author":"Karpecki","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2015.08.023_bib0040","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/chir.22042","article-title":"Determination of enantiomeric impurity in besifloxacin hydrochloride by chiral high-performance liquid chromatography with precolumn derivatization","volume":"24","author":"Wang","year":"2012","journal-title":"Chirality"},{"key":"10.1016\/j.jpba.2015.08.023_bib0045","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.talanta.2013.10.051","article-title":"Quantitative evaluation of besifloxacin ophthalmic suspension by HPLC, application to bioassay method and cytotoxicity studies","volume":"119","author":"Costa","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2015.08.023_bib0050","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jop.2008.0116","article-title":"Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans","volume":"25","author":"Proksch","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2015.08.023_bib0055","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1089\/jop.2010.0054","article-title":"Ocular pharmacokinetics\/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits","volume":"26","author":"Proksch","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2015.08.023_bib0060","first-page":"331","article-title":"Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration","volume":"4","author":"Torkildsen","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jpba.2015.08.023_bib0065","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jcrs.2010.12.046","article-title":"Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application","volume":"37","author":"Donnenfeld","year":"2011","journal-title":"J. Cataract Refract. Surg."},{"key":"10.1016\/j.jpba.2015.08.023_bib0070","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jchromb.2008.03.025","article-title":"Quantitative determination of besifloxacin, a novel fluoroquinolone antimicrobial agent, in human tears by liquid chromatography\u2013tandem mass spectrometry","volume":"867","author":"Arnold","year":"2008","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2015.08.023_bib0075","first-page":"263","article-title":"Notes on the use of propagation of error formulas","volume":"70C","author":"Ku","year":"1966","journal-title":"J. Res. Nat. Bur. Stand"},{"key":"10.1016\/j.jpba.2015.08.023_bib0080","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1002\/jps.23557","article-title":"Propagation of error in ocular pharmacokinetic parameters estimate of azithromycin in rabbits","volume":"102","author":"You","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2015.08.023_bib0085","unstructured":"US Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Guidance for Industry, Bioanalytical Method Validation. Available at: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm368107."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515301217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:01:23Z","timestamp":1589569283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515301217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":17,"alternative-id":["S0731708515301217"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.08.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid, sensitive and selective HPLC\u2013MS\/MS method for the quantification of topically applied besifloxacin in rabbit plasma and ocular tissues: Application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}